CZ20021551A3 - Onkolytické kombinace pro léčení rakoviny - Google Patents

Onkolytické kombinace pro léčení rakoviny Download PDF

Info

Publication number
CZ20021551A3
CZ20021551A3 CZ20021551A CZ20021551A CZ20021551A3 CZ 20021551 A3 CZ20021551 A3 CZ 20021551A3 CZ 20021551 A CZ20021551 A CZ 20021551A CZ 20021551 A CZ20021551 A CZ 20021551A CZ 20021551 A3 CZ20021551 A3 CZ 20021551A3
Authority
CZ
Czechia
Prior art keywords
pgi
ethyl
phenoxy
propoxy
mmol
Prior art date
Application number
CZ20021551A
Other languages
Czech (cs)
English (en)
Inventor
Jerome Herbert Fleisch
Roger Stuart Benjamin
Jason Scott Sawyer
Beverly Ann Teicher
Douglas Wade Beight
Edward C. R. Smith
William Thomas Mcmillen
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of CZ20021551A3 publication Critical patent/CZ20021551A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
CZ20021551A 1999-11-11 2000-11-09 Onkolytické kombinace pro léčení rakoviny CZ20021551A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16478699P 1999-11-11 1999-11-11

Publications (1)

Publication Number Publication Date
CZ20021551A3 true CZ20021551A3 (cs) 2003-02-12

Family

ID=22596085

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20021551A CZ20021551A3 (cs) 1999-11-11 2000-11-09 Onkolytické kombinace pro léčení rakoviny

Country Status (22)

Country Link
EP (1) EP1231938A2 (fr)
JP (1) JP2003513916A (fr)
KR (1) KR20020069512A (fr)
CN (1) CN1390139A (fr)
AR (1) AR032432A1 (fr)
AU (1) AU778829B2 (fr)
BR (1) BR0015490A (fr)
CA (1) CA2391416A1 (fr)
CZ (1) CZ20021551A3 (fr)
EA (1) EA200200545A1 (fr)
HK (1) HK1050132A1 (fr)
HU (1) HUP0204449A3 (fr)
IL (1) IL148579A0 (fr)
MX (1) MXPA02004733A (fr)
NO (1) NO20022245L (fr)
NZ (1) NZ517667A (fr)
PE (1) PE20010701A1 (fr)
PL (1) PL355172A1 (fr)
SK (1) SK6492002A3 (fr)
TR (1) TR200201245T2 (fr)
WO (1) WO2001034137A2 (fr)
ZA (1) ZA200202822B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1916501A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
US6797723B1 (en) 1999-11-11 2004-09-28 Eli Lilly And Company Heterocycle substituted diphenyl leukotriene antagonists
AU1916601A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
JP2001247459A (ja) 2000-03-03 2001-09-11 Oakland Uniservices Ltd 癌の組み合わせ療法
JP2003532675A (ja) * 2000-05-09 2003-11-05 クレイトン ユニバーシティ 癌細胞の増殖を阻害しそのアポトーシスを誘導する方法
WO2002009700A1 (fr) 2000-07-28 2002-02-07 Cancer Research Technology Limited Traitement combine contre le cancer
GB0121285D0 (en) 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
WO2005105736A1 (fr) 2004-05-05 2005-11-10 Novo Nordisk A/S Nouveaux composes, leur preparation et leur utilisation
WO2005105726A1 (fr) 2004-05-05 2005-11-10 Novo Nordisk A/S Nouveaux composes, leur preparation et leur utilisation
CN1302782C (zh) * 2005-01-17 2007-03-07 北京京卫燕康药物研究所有限公司 盐酸吉西他滨溶液型注射剂
AU2006265172B2 (en) 2005-06-30 2011-09-15 Vtv Therapeutics Llc Phenoxy acetic acids as PPAR delta activators
EA201101085A1 (ru) 2005-12-22 2012-05-30 ХАЙ ПОЙНТ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи Феноксиуксусные кислоты в качестве активаторов ppar дельта
WO2007101864A2 (fr) 2006-03-09 2007-09-13 High Point Pharmaceuticals, Llc Nouveaux composés, leur préparation et utilisation
AU2007307597A1 (en) 2006-10-12 2008-04-17 Institute Of Medicinal Molecular Design. Inc. Carboxylic acid derivatives
US8633245B2 (en) 2008-04-11 2014-01-21 Institute Of Medicinal Molecular Design, Inc. PAI-1 inhibitor
WO2014060381A1 (fr) 2012-10-18 2014-04-24 Bayer Cropscience Ag Composés hétérocycliques pour la lutte contre les nuisibles
BR112015009751A2 (pt) 2012-10-31 2017-07-11 Bayer Cropscience Ag novos compostos heterocíclicos como pesticidas
CN103319466B (zh) * 2013-07-04 2016-03-16 郑州大学 含香豆素母核的1,2,3-三唑-氨基二硫代甲酸酯化合物、制备方法及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation

Also Published As

Publication number Publication date
AU778829B2 (en) 2004-12-23
PL355172A1 (en) 2004-04-05
KR20020069512A (ko) 2002-09-04
ZA200202822B (en) 2003-09-23
NO20022245L (no) 2002-07-09
WO2001034137A2 (fr) 2001-05-17
NO20022245D0 (no) 2002-05-10
JP2003513916A (ja) 2003-04-15
AU1599001A (en) 2001-06-06
WO2001034137A3 (fr) 2002-02-14
CN1390139A (zh) 2003-01-08
BR0015490A (pt) 2002-07-09
SK6492002A3 (en) 2003-09-11
AR032432A1 (es) 2003-11-12
HUP0204449A2 (hu) 2003-04-28
HK1050132A1 (zh) 2003-06-13
PE20010701A1 (es) 2001-07-07
EA200200545A1 (ru) 2002-12-26
MXPA02004733A (es) 2002-08-30
HUP0204449A3 (en) 2006-02-28
IL148579A0 (en) 2002-09-12
EP1231938A2 (fr) 2002-08-21
CA2391416A1 (fr) 2001-05-17
TR200201245T2 (tr) 2004-08-23
NZ517667A (en) 2004-05-28

Similar Documents

Publication Publication Date Title
CZ20021551A3 (cs) Onkolytické kombinace pro léčení rakoviny
TWI612040B (zh) 作爲選擇性雌激素受體降解子（ｓｅｒｄ）之化合物及組合物
ES2397664T3 (es) Derivados de glucopiranósilo que contienen tienilo como antidiabéticos
TWI331034B (en) Inhibitors of cyclin-dependent kinases and their use
KR20100137551A (ko) 벤조피란 및 벤족세핀 ｐｉ３ｋ 저해제 화합물 및 이의 사용 방법
TW446704B (en) Naphtho[2,3-B]heteroar-4-yl derivatives for treating metabolic disorders related to insulin resistance or hyperglycemia
JP2003531194A (ja) プロスタグランジンｅ阻害薬としてフェニルおよびビアリール誘導体を用いる治療方法および該方法に有用な化合物
US4551282A (en) Triphenylene derivatives
KR20120107526A (ko) 페닐 ｃ?글루코사이드 유도체 및 그의 제조 방법 및 용도
CN106188045A (zh) 作为wnt信号传导抑制剂的化合物、组合物及其应用
US20150011618A1 (en) Synthesis of polyhydroxy chromenone compounds and their anti-tumor effects
JP6461080B2 (ja) 二重ｓｇｌｔ１／ｓｇｌｔ２阻害剤
TW200845961A (en) Tricyclic compounds useful in treating iron disorders
JP2003509419A (ja) カルボン酸類およびアシルスルホンアミド類、そのような化合物を含む組成物、ならびに治療方法
WO2005079803A1 (fr) Composes pour traitement des maladies cardio-vasculaires
AU2041801A (en) Oncolytic combinations for the treatment of cancer
CN117597341A (zh) 磺酰胺衍生物、其制备方法及其在医药上的应用
CN107074873A (zh) 作为抗癌药的7‑(吗啉基)‑2‑(N‑哌嗪基)甲基噻吩并[2，3‑c]吡啶衍生物
JP6223336B2 (ja) 新規なエストロゲン受容体リガンド
WO2001034198A2 (fr) Combinaisons oncolytiques pour traitement des cancers
WO2001034197A2 (fr) Combinaisons oncolytiques aux fins du traitement de cancer
CN102781924A (zh) 用作过氧化物酶体增殖剂激活受体的配体的硒唑衍生物、其制备方法及其化合物的用途
KR20160142887A (ko) 폴리시클릭 hERG 활성화제
CN101146804B (zh) 用作抗癌剂的5-（1，3-二芳基-1h-吡唑-4-基亚甲基）-噻唑烷-2，4-二酮衍生物
MXPA02004646A (es) Antagonistas de leucotrieno de difenilo substituido con heterociclo.